• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » addiction

Articles Tagged with ''addiction''

Research Update

Buprenorphine versus Methadone for Prescription Opioid Use Disorder

April 1, 2024
Richard Moldawsky, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

Methadone treatment for OUD typically comes with a high level of supervision whereas buprenorphine is often flexibly dosed and taken at home. Here researchers wanted to know how patients of a closely supervised methadone clinic compared with those taking buprenorphine prescribed in an office setting. The findings might surprise you.


Read More
Clinical Update

Three Buprenorphine Dosing Strategies When Transitioning From Other Opioids

April 1, 2024
Monthe Kofos, DO and Noah Capurso, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Monthe Kofos, DO. Addiction Psychiatry Fellow, Yale University, New Haven, CT.

Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Kofos and Dr. Capurso have no financial relationships with companies related to this material.

The process of starting a patient on buprenorphine, called an induction, can be a bit tricky and puts a patient at risk of a precipitated opioid withdrawal. In this article, we discuss the three most common buprenorphine induction approaches, review the pros and cons of each, and include straightforward guidance that will help you perform a successful buprenorphine induction for your patients.



Read More
psychedilics.png
Expert Q&A

Psychedelics and Addiction

April 1, 2024
Snehal Bhatt, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue
CATR_QA1_SBhatt-_NEWPhoto.pngSnehal Bhatt, MD.

Chief, Addiction Psychiatry; Professor, Psychiatry and Behavioral Sciences, University of New Mexico, Albuquerque, NM.

Dr. Bhatt has no financial relationships with companies related to this material.

Dr. Bhatt outlines the latest developments in therapeutic uses of psychedelic medications. He highlights the great opportunities as well as the potential drawbacks. He details some of his own work in the use of psilocybin for the treatment of alcohol use disorder and advises clinicians how to discuss psychedelics with their patients.


Read More
shutterstock_2423345401_Ekkasit A Siam.png
CARLAT WEBINAR

Motivational Interviewing for Teens: Focus on Marijuana

February 15, 2024
Joshua Feder, MD

0.50 CME Credits. Key strategies to empower you in reducing marijuana use among you. Join us as we delve into practical approaches to support teens in making healthier choices and navigating the stages of change.


Read More
Clinical Update

A Spotlight on Two Emerging Nootropics

February 10, 2024
Jeremy Weleff, DO., Akhil Anand, MD., and Julian J. Raffoul, MD, PhD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Jeremy Weleff, DO. Yale School of Medicine, New Haven, CT; Cleveland Clinic, Cleveland, OH. Akhil Anand, MD. Cleveland Clinic, Cleveland, OH. Julian J. Raffoul, MD, PhD. Vanderbilt University Medical Center, Nashville, TN.

Dr. Weleff, Dr. Anand, and Dr. Raffoul have no financial relationships with companies related to this material.

Nootropics are a broad class of medications encompassing many different mechanisms of action that are marketed as cognitive enhancers. Not only do most nootropics lack evidence of efficacy, but some can have dangerous side effects and addictive potential. Here, we discuss some of the most concerning nootropics being widely used today.


Read More
Research Update

Perinatal MOUD Use and Infant Discharge to Biological Parents

October 31, 2023
Destiny Pegram, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Destiny Pegram, MD. Dr. Pegram has no financial relationships with companies related to this material.

Pregnant patients with OUD may be reluctant to reveal their substance use for fear of losing their baby if reported to Child Protective Services. But this recent study shows that pregnant patients receiving medication treatment for OUD were more likely to leave the hospital with their baby than patients not receiving treatment.


Read More
Research Update

Can Psilocybin Treat Alcohol Use Disorder?

October 31, 2023
Aniruddha Deka, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Aniruddha Deka, MD. Dr. Deka has no financial relationships with companies related to this material. 

Recent preliminary research reveals that psilocybin helped participants with alcohol use disorder cut back on drinking. Dive in to discover how this psychedelic compound might offer hope for patients who have found other current treatments ineffective.


Read More
Expert Q&A

When and How Should We Prescribe Benzos?

October 31, 2023
Tae Woo (Ted) Park, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

QA_Benzo-Prescribing_TaeWooPark.JPGTae Woo (Ted) Park, MD. Assistant professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Dr. Park has no financial relationships with companies related to this material. 

Despite their risks, benzodiazepines remain a widely prescribed class of medication. In the prescriber right hands, benzodiazepines can help many patients cope with a variety of psychiatric issues. Here, Dr. Park reviews how to evaluate patients prior to starting benzodiazepines and reviews strategies to ensure that prescriptions are done safely.


Read More
Expert Q&A

Deprescribing Benzos: A How-To Guide

October 31, 2023
Audrey Abelleira, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

QA_Addiction--Prescriptions_Abelleira.jpgAudrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.


Benzodiazepines are widely prescribed but carry significant risks. The best course of action for many patients is to have their benzodiazepine prescription discontinued, but physiologic dependence can make stopping benzodiazepines a big challenge. Dr. Abeillera teaches us how to identify those who might benefit from a taper and covers all the details on how to do it as safely and effectively as possible. 


Read More
TCPR_July2023_manwithmedication_thumb.jpg
Expert Q&A

Prescription Drug Misuse

July 3, 2023
Joseph Pierre, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

JoePierreMD_thumb.jpgJoseph Pierre, MD.

Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.

Dr. Pierre has no financial relationships with companies related to this material.

Medication misuse requires more than telling your patient, “Just say no.” Dr. Pierre shows us how to keep the conversation firm but therapeutic.


Read More
Previous 1 2 3 4 5 6 7 8 9 … 22 23 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • PB5e_3DCover.png

    Psychiatry Practice Boosters, Fifth Edition (2026)

    This fifth edition teaches you the key points of 66 of the most clinically relevant studies in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2694929461.jpg
    Child Psychiatry

    ADHD in Young Adults: Assessment, Daily Functioning, and Support That Fits

    Working with young adults who are navigating ADHD is rarely straightforward. They’re often dealing with more than just distractibility or missed deadlines. There’s anxiety,...

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.